Searched for
PIL AGAINST RANBAXY
Political, business bigwigs suffer setback in Delhi HC in 2019The list include senior Congress leaders like Sonia Gandhi and Rahul Gandhi in the National Herald case and Chidambaram in the INX media ca...- Ranbaxy whistle blower Dinesh Thakur suggests strict prosecution laws to fix drug industryDinesh Thakur says the country needs strict criminal prosecution against suppliers of substandard drugs, a nationwide product recall system.
- How drug whistle-blowers in India have to fight a long battleThe fight by whistle-blowers for drug quality in India has cost them their dignity, jobs, and left them in severe financial duress.
- Not aware of adverse findings about manufacturing units of Ranbaxy: Sun Pharma“Based on our understanding of the matter, there is no truth to the assertions you are making,” a Sun spokesperson said in an email to ET.
- Ranbaxy whistleblower Dinesh Thakur may join PIL in Supreme CourtSharma wants three manufacturing sites banned on the grounds that they allegedly supplied adulterated drugs from these facilities.
- Whistleblower raises questions on DCGI, drug regulatory systemIn a writ petition filed at the Supreme Court of India, Thakur has sued the health ministry , Central Drugs Standard Control Organisation .
- Coal, telecom, mining giants bite dust in Supreme Court in 2014Corporate legal cases kept India Inc on its toes in 2014 as high stake matters on coal, telecom and mining came up in the Supreme Court.
- Drugs sold by company in the Indian market are safe: RanbaxyRanbaxy insisted drugs sold by it in the Indian market are safe and effective and the company complies with country's regulations.
- SC notice to Centre, Ranbaxy on plea for cancelling its licenceThe court passed the order on a PIL filed by advocate M L Sharma seeking action against the company for allegedly supplying sub standard an...
- Ranbaxy facilities under review: Gulam Nabi AzadRanbaxy facilities in India are being reviewed after its US arm admitted to manufacturing certain drugs not in conformity with good practic...
- Supreme Court dismisses plea against RanbaxyThe SC has dismissed for want of proof a public interest litigation seeking a probe against Ranbaxy Labs for making and marketing substanda...
- Stake buy in Mozambique field a good deal for ONGC: Taher Badshah, Motilal Oswal AMC"The stock corrected recently due to the postponement of the gas price hike, but that is something which is more or less an eventuality," s...
- Ranbaxy gains momentum as SC rejects PILRanjit Kapadia, Senior VP, Centrum Broking doesn’t expect too much upside in the stock. The outcome was on expected lines, he said to ET No...
- Supreme Court to hear plea against Ranbaxy Laboratories on June 24SC will hear on June 24 a petition seeking probe against Ranbaxy Labs for allegedly manufacturing and selling adulterated medicines.
- We will continue on our growth plans: Arun Sawhney, Ranbaxy"Ranbaxy is the number one pharmaceutical company from India. We have inherently great strengths. "
- PIL against Ranbaxy: Supreme Court asks advocate to substantiate allegationsSharma, in his PIL, has sought cancellation of the license granted to Ranbaxy Laboratories and initiation of probe against it.
- Supreme Court to hear PIL on Ranbaxy next weekThe SC agreed to hear next week a PIL seeking cancellation of license granted to Ranbaxy Laboratories.
- Supreme Court to hear PIL against Ranbaxy Laboratories next weekThe today agreed to hear next week a PIL seeking cancellation of license granted to Ranbaxy Laboratories.
- PIL seeking cancellation of Ranbaxy licence filed in Supreme CourtA plea has been filed in the SC seeking cancellation of Ranbaxy's licence on the grounds that it fudged data and sold adulterated products ...
- PIL in Supreme Court for action against RanbaxyAn advocate today approached the Supreme Court with a PIL seeking cancellation of the license granted to Ranbaxy Laboratories Ltd and for i...
Load More
